Table of Contents
Overview
Major Corporate Events in Cardiology?A Year-End Bidding War over Drug-Eluting
Stents
- A Brief Look at Guidant
- Why Guidant Was Attractive to Johnson & Johnson
- Why Guidant Was Attractive to Boston Scientific
- Backed by Abbott, Boston Scientific Prevails
- Warning Letter from the FDA and Device Safety Issues
- Patent Struggles Continue
- Future Acquisition Candidates for Johnson & Johnson
Financings
- Initial Public Offerings
- Secondary Public Offerings
- Debt Financings
- Private Placements and Venture Capital
Ownership Changes
- Novartis/Chiron
- Allergan/Inamed
- Amgen/Abgenix
- St. Jude Medical/Advanced Neuromodulation Systems
Alliances
- AstraZeneca/AtheroGenics
- Pfizer/Incyte
- AstraZeneca/Protherics
- Roche/BioCryst Pharmaceuticals
- Novartis/Astex Therapeutics
Most Active Pharmaceutical Companies
Most Active Biotechnology Companies
View Cart
